Searle & Co.
Source: SEC Form 13F · as of Mar 2026Searle & Co. holds 18 biotech & pharma companies tracked by BioSniper, totaling $60.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$60.3M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 48,077 | $10.5M |
| JNJJOHNSON & JOHNSON | 39,034 | $9.5M |
| PMPhilip Morris International Inc | 56,301 | $9.3M |
| MRKMerck & Co., Inc. | 53,163 | $6.4M |
| BMYBRISTOL MYERS SQUIBB CO | 79,811 | $4.8M |
| AZNASTRAZENECA PLC | 17,675 | $3.4M |
| LLYELI LILLY & Co | 3,000 | $2.8M |
| RPRXRoyalty Pharma plc | 56,500 | $2.7M |
| PFEPFIZER INC | 87,762 | $2.5M |
| AMGNAMGEN INC | 6,771 | $2.4M |
| FMSFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) | 80,725 | $1.8M |
| ABTABBOTT LABORATORIES | 17,068 | $1.8M |
| ELVElevance Health Inc. | 2,356 | $690K |
| DGXQuest Diagnostics Incorporated | 2,500 | $490K |
| SNYSanofi | 10,000 | $482K |
| ZTSZoetis Inc. | 3,260 | $385K |
| GILDGILEAD SCIENCES, INC. | 2,050 | $286K |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 86,250 | $69K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.